Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06131931 · ClinicalTrials.gov registry record · NA

HIV Prevention Intervention for Latino Male Couples

A NA study of HIV, sponsored by University of Central Florida.

Recruiting
Registry status
NA
Development phase
400
Enrollment target
1
Study location

NCT06131931 is a NA study of HIV that is actively recruiting participants, run by University of Central Florida. The registered enrollment target is 400 participants, roughly in line with the 439-participant average among 303 other HIV trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06131931, a NA study of HIV, is actively recruiting participants, sponsored by University of Central Florida.

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this proposal is to test the efficacy of Connecting Latinxs en Pareja (CLP). CLP is a four-session intervention grounded in social cognitive theory and a relationship oriented ecological framework. The investigators will examine whether participants assigned to CLP report an increase in the proportion of HIV protected anal sex acts to those assigned to a Wellness Promotion (WP) time and attention matched control condition. The primary outcome, relates to use of HIV protection.

Conditions Studied

Interventions

  • OTHER CLP Intervention
  • OTHER WP Intervention

Study Locations (1)

Florida

  • University of Central Florida - Orlando

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2023-06-21
Est. Completion 2028-06
Phase NA

Sponsor

University of Central Florida

91 total trials

What the Registry Record Tells You About NCT06131931

The ClinicalTrials.gov registry entry for NCT06131931 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 439-participant average among 303 other HIV trials with a reported enrollment target. The listed sponsor is University of Central Florida, which has 91 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 2 interventions - of which CLP Intervention is the first listed.

NCT06131931 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06131931 about?

NCT06131931 is a clinical study titled "HIV Prevention Intervention for Latino Male Couples". The primary objective of this proposal is to test the efficacy of Connecting Latinxs en Pareja (CLP). CLP is a four-session intervention grounded in social cognitive theory and a relationship oriented ecological framework. The investigators will examine whether participants assigned to CLP report a...

What is the current status of trial NCT06131931?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2023-06-21. Estimated completion is 2028-06.

What conditions does trial NCT06131931 study?

This clinical trial studies the following conditions: HIV.

What interventions are being tested in trial NCT06131931?

The interventions under investigation include: CLP Intervention (OTHER), WP Intervention (OTHER).

Who is sponsoring clinical trial NCT06131931?

This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06131931 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.